Table of Contents Author Guidelines Submit a Manuscript
Volume 8, Pages 470-485
Review Article

Vasoactive Hormones and the Diabetic Kidney

Department of Medicine, Georgetown University Medical Center, Washington, DC, USA

Received 5 September 2007; Revised 12 March 2008; Accepted 31 March 2008

Academic Editor: Mark Cooper

Copyright © 2008 Christine Maric.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Sebastian Martini, Felix Eichinger, Viji Nair, and Matthias Kretzler, “Defining human diabetic nephropathy on the molecular level: Integration of transcriptomic profiles with biological knowledge,” Reviews in Endocrine and Metabolic Disorders, vol. 9, no. 4, pp. 267–274, 2008. View at Publisher · View at Google Scholar
  • Xuejing Zhu, Fuyou Liu, Youming Peng, Hong Liu, Shuguang Yuan, Xiangqing Xu, Yinghong Liu, Lin Sun, and Guanghui Ling, “New pathologic classification of diabetic nephropathy (retrospective study of 37 cases),” Journal of Central South University (Medical Sciences), vol. 37, no. 2, pp. 185–189, 2012. View at Publisher · View at Google Scholar
  • Carlos E.N. Amorim, Ronaldo C. Araujo, Eliana Nogueira, Sandro S. Almeida, Pedro P.G. Gomes, Reury F.P. Bacurau, K. Suzete Ozaki, Marcos A. Cenedeze, Alvaro P. Silva Filho, and Niels O.S. Câmara, “Clinical impact of an angiotensin I-converting enzyme insertion/deletion and kinin B2 receptor +9/-9 polymorphisms in the prognosis of renal transplantation,” Biological Chemistry, vol. 394, no. 3, pp. 369–377, 2013. View at Publisher · View at Google Scholar
  • Alessandro Pini, Roberta Verta, Cristina Grange, Maura Gurrieri, and Arianna Carolina Rosa, “Histamine and diabetic nephropathy: an up-to-date overview,” Clinical Science, vol. 133, no. 1, pp. 41–54, 2019. View at Publisher · View at Google Scholar